A C.D.C. panel weighs the risks of blood clots linked to the J.&J. vaccine.

Public health experts cite concerns about the increased incidence of a rare but potentially serious blood clotting condition among those who received the company’s shot.

View original article
Contributor: Rebecca Robbins and Christina Jewett